<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Over the last 15 years progressive interest has developed in the relationship between <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo>, sympathetic <z:mp ids='MP_0008912'>nervous</z:mp> system over-activity and the genesis of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral artery spasm</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Following on from earlier work, vide infra, suggesting that adrenergic blockade might influence the course and prognosis of patients with <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo>, two double blind trials have recently been completed in Southampton </plain></SENT>
<SENT sid="2" pm="."><plain>The first trial attempted to establish whether or not a single intracarotid injection of phenoxybenzamine improved the mortality and late morbidity of patients with <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Results suggested that it did not </plain></SENT>
<SENT sid="4" pm="."><plain>The second trial, comprising two groups of 50 patients each, attempted to assess the influence of prolonged treatment with <z:chebi fb="2" ids="8499">propranolol</z:chebi> on the course and prognosis of these <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> patients </plain></SENT>
<SENT sid="5" pm="."><plain>Early results suggest that, as with the alpha-blocker, the mortality and severe morbidity was not improved by beta-adrenergic blockade </plain></SENT>
</text></document>